This is the authors' abstract. We don't add key points for this paper.
The spillover of pathogenic hantaviruses from rodent reservoirs into the human population poses a continued threat to human health. Here, we show that a recombinant form of the Hantaan virus (HTNV) surface-displayed glycoprotein, Gn, elicits a neutralizing antibody response in rabbits. We isolated a neutralizing (HTN-Gn1) and a non-neutralizing (nnHTN-Gn2) monoclonal antibody and provide the first molecular-level insights into how the Gn glycoprotein may be targeted by the antibody-mediated immune response. These findings may guide rational vaccine design approaches focused on targeting the hantavirus glycoprotein envelope.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rissanen et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: